EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
Dafsari, Haidar S. MD *,1,2; Martinez-Martin, Pablo MD, PhD 3; Rizos, Alexandra MSc 2; Trost, Maja MD 4; dos Santos Ghilardi, Maria Gabriela MD 5; Reddy, Prashanth MD/PhD 2; Sauerbier, Anna MD 2,6; Petry-Schmelzer, Jan Niklas MD 1; Kramberger, Milica MD 4; Borgemeester, Robbert W. K. MD 7; Barbe, Michael T. MD 1; Ashkan, Keyoumars MD, PhD 2; Silverdale, Monty MD, PhD 8; Evans, Julian MD, PhD 8; Odin, Per MD, PhD 9,10; Fonoff, Erich Talamoni MD, PhD 5,11; Fink, Gereon R. MD 1,12; Henriksen, Tove MD, PhD 13; Ebersbach, Georg MD 14; Pirtosek, Zvezdan MD, PhD 4; Visser-Vandewalle, Veerle MD, PhD 15; Antonini, Angelo MD, PhD 16,17; Timmermann, Lars MD 1,18; Ray Chaudhuri, K. MD, PhD *,2,6; on behalf of EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group
[Article] Movement Disorders. 34(3):353-365, March 2019.

(Format: HTML, PDF)